Display Settings:

Format

Send to:

Choose Destination

    Biochem Biophys Res Commun. 2005 Jan 7;326(1):242-8.

    The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression.

    Suzuki H, Kurita M, Mizumoto K, Moriyama M, Aiso S, Nishimoto I, Matsuoka M.

    Department of Pharmacology, KEIO University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo160-8582, Japan.

    The ARF tumor suppressor gene antagonizes generation of various tumors. ARF-mediated tumor suppression occurs in a p53-independent manner as well as in a p53-dependent manner. We here demonstrate that BCL6 is a target of the ARF tumor suppressor. Either mouse p19(ARF) or human p14(ARF) binds to BCL6 and downregulates BCL6-induced transcriptional repression. ARF-mediated downregulation of the BCL6 activity may account in part for ARF-mediated tumor suppression.

    PMID: 15567177 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read